Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Care Facilities

Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Revenue projections:

Revenue projections for NH
Revenue projections for NH

Revenues for NH are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 0.000000
forwardPE 32.162735
debtToEquity 66.930000
earningsGrowth -0.024000
revenueGrowth 0.124000
grossMargins 0.431380
operatingMargins 0.167620
trailingEps 38.680000
forwardEps 42.150000

NH's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that NH is likely to outperform its previous year's financial performance.

Price projections:

Price projections for NH
Price projections for NH

Price projections for NH have gradually risen over time, signaling increased optimism about the company's future prospects. This steady upward revision reflects growing confidence in NH's market potential.

Recommendation changes over time:

Recommendations trend for NH
Recommendations trend for NH


Analysts have given a mixed assessment of NH, refraining from clear buy or sell recommendations. This ambiguity may leave investors unsure of the stock's outlook, encouraging them to consider broader market trends and other investment signals before making any moves.